Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sotera Health (SHC) Net Income towards Common Stockholders (2020 - 2026)

Sotera Health has reported Net Income towards Common Stockholders over the past 6 years, most recently at $34.8 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 182.78% year-over-year to $34.8 million; the TTM value through Dec 2025 reached $77.9 million, up 75.57%, while the annual FY2025 figure was $77.9 million, 75.57% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $34.8 million at Sotera Health, down from $48.4 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $48.4 million in Q3 2025 and troughed at -$319.7 million in Q4 2022.
  • A 5-year average of $2.9 million and a median of $20.3 million in 2023 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: surged 4263.12% in 2021 and later plummeted 988.18% in 2022.
  • Year by year, Net Income towards Common Stockholders stood at $36.0 million in 2021, then plummeted by 988.18% to -$319.7 million in 2022, then surged by 112.1% to $38.7 million in 2023, then tumbled by 68.14% to $12.3 million in 2024, then skyrocketed by 182.78% to $34.8 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for SHC at $34.8 million in Q4 2025, $48.4 million in Q3 2025, and $8.0 million in Q2 2025.